Herbal and Non-Herbal Dietary Supplements for Psychiatric Indications: Considerations in Liver Transplantation

Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363. https://doi.org/10.1186/s12906-020-03157-2.

Article  PubMed  PubMed Central  Google Scholar 

Purohit MP, Wells RE, Zafonte RD, Davis RB, Phillips RS. Neuropsychiatric symptoms and the use of complementary and alternative medicine. PM R. 2013;5(1):24–31. https://doi.org/10.1016/j.pmrj.2012.06.012.

Article  PubMed  Google Scholar 

Traditional medicine. https://www.who.int/news-room/questions-and-answers/item/traditional-medicine. Accessed 06 June 2024.

Asher GN, Gerkin J, Gaynes BN. Complementary therapies for mental health disorders. Med Clin North Am. 2017;101(5):847–64. https://doi.org/10.1016/j.mcna.2017.04.004.

Article  PubMed  Google Scholar 

Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, et al. Canadian Network for Mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Sect. 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576–87. https://doi.org/10.1177/0706743716660290.

Article  PubMed  PubMed Central  Google Scholar 

Barić H, Đorđević V, Cerovečki I, Trkulja V. Complementary and alternative medicine treatments for generalized anxiety disorder: systematic review and Meta-analysis of Randomized controlled trials. Adv Ther. 2018;35(3):261–88. https://doi.org/10.1007/s12325-018-0680-6.

Article  PubMed  Google Scholar 

Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG et al. Integrative Oncology Care of symptoms of anxiety and depression in adults with Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 2023:4562–91. https://doi.org/10.1200/JCO.23.00857.

Crone CC, Wise TN. Survey of alternative medicine use among organ transplant patients. J Transpl Coord. 1997;7(3):123–30. https://doi.org/10.7182/prtr.1.7.3.j651880137772172.

Article  CAS  PubMed  Google Scholar 

Osman NA, Hassanein SM, Leil MM, NasrAllah MM. Complementary and alternative medicine use among patients with chronic kidney disease and kidney transplant recipients. J Ren Nutr. 2015;25(6):466–71. https://doi.org/10.1053/j.jrn.2015.04.009.

Article  PubMed  Google Scholar 

Matthees BJ, Anantachoti P, Kreitzer MJ, Savik K, Hertz MI, Gross CR. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung. 2001;30(4):258–68. https://doi.org/10.1067/mhl.2001.116135.

Article  CAS  PubMed  Google Scholar 

Henson JB, Brown CL, Chow SC, Muir AJ. Complementary and alternative medicine use in United States adults with liver disease. J Clin Gastroenterol. 2017;51(6):564–70. https://doi.org/10.1097/MCG.0000000000000617.

Article  PubMed  PubMed Central  Google Scholar 

Neff GW, O’Brien C, Montalbano M, DeManno A, Kahn S, Safdar K, et al. Consumption of dietary supplements in a liver transplant population. Liver Transpl. 2004;10(7):881–85. https://doi.org/10.1002/lt.20183.

Article  PubMed  Google Scholar 

Tickerhoof L, Wagener MM, Cacciarelli TV, Singh N. Alternative therapy use in liver transplant recipients. Prog Transplantation. 2006;16(3):226–31. https://doi.org/10.1177/152692480601600307.

Article  Google Scholar 

Heinrich TW, Marcangelo M. Psychiatric issues in solid organ transplantation. Harv Rev Psychiatry 2009:17(6): 398–406. https://doi.org/10.3109/10673220903463259.

Faeder S, Moschenross D, Rosenberger E, Dew MA, DiMartini A. Psychiatric aspects of organ transplantation and donation. Curr Opin Psychiatry. 2015;28(5):357–64. https://doi.org/10.1097/YCO.0000000000000185.

Article  PubMed  PubMed Central  Google Scholar 

Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399–408. https://doi.org/10.1002/hep.27317.

Article  PubMed  Google Scholar 

Wong LL, Lacar L, Roytman M, Orloff SL. Urgent liver transplantation for dietary supplements: an under-recognized problem. Transpl Proc. 2017;49(2):322–25. https://doi.org/10.1016/j.transproceed.2016.11.041.

Article  CAS  Google Scholar 

Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol 2016: 111(7):958–65. https://doi.org/10.1038/ajg.2016.114.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340–52. .e7.

Article  PubMed  Google Scholar 

Francis P, Navarro VJ. Drug-Induced Hepatotoxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK557535/. Accessed May 2, 2024.

Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023: 1;77(3):1036-65. Practice guidance with expert opinion-based recommendations regarding recognition, risk-stratification, and management of drug-induced liver injury.

Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014;171(4):404–15. https://doi.org/10.1176/appi.ajp.2013.13050709.

Article  PubMed  Google Scholar 

Gunther M, Dopheide JA. Antipsychotic safety in liver disease: a narrative review and practical guide for the clinician. J Acad Consult Liaison Psychiatry. 2023;64(1):73–82. https://doi.org/10.1016/j.jaclp.2022.09.006.

Article  PubMed  Google Scholar 

Todorović Vukotić N, Đorđević J, Pejić S, Đorđević N, Pajović SB. Antidepressants- and antipsychotics-induced hepatotoxicity. Arch Toxicol. 2021;95(3):767–89. https://doi.org/10.1007/s00204-020-02963-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savage K, Firth J, Stough C, Sarris J. GABA-modulating phytomedicines for anxiety: a systematic review of preclinical and clinical evidence. Phytother Res. 2018;32(1):3–18. https://doi.org/10.1002/ptr.5940.

Article  CAS  PubMed  Google Scholar 

Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Med (Baltim). 2019;98(37):e17186. https://doi.org/10.1097/MD.0000000000017186.

Article  CAS  Google Scholar 

Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults. Sleep Med. 2020;72:28–36. https://doi.org/10.1016/j.sleep.2020.03.012.

Article  PubMed  Google Scholar 

Gopukumar K, Thanawala S, Somepalli V, Rao TSS, Thamatam VB, Chauhan S. Efficacy and safety of Ashwagandha Root Extract on cognitive functions in healthy, stressed adults: a Randomized, Double-Blind, placebo-controlled study. Evid Based Complement Alternat Med. 2021;20218254344. https://doi.org/10.1155/2021/8254344.

Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825–29. https://doi.org/10.1111/liv.14393.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philips CA, Valsan A, Theruvath AH, Ravindran R, Oommen TT, Rajesh S, et al. Ashwagandha-induced liver injury-A case series from India and literature review. Hepatol Commun. 2023;7(10):e0270. https://doi.org/10.1097/HC9.0000000000000270.

Article  PubMed  PubMed Central  Google Scholar 

Suryawanshi G, Abdallah M, Thomson M, Desai N, Chauhan A, Lim N. Ashwagandha-associated acute liver failure requiring liver transplantation. Am J Ther. 2023;30(1):e80–3. https://doi.org/10.1097/MJT.0000000000001466.

Article  PubMed  Google Scholar 

Rothenberg DO, Zhang L. Mechanisms underlying the anti-depressive effects of regular tea consumption. Nutrients. 2019;11(6):1361. https://doi.org/10.3390/nu11061361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S. Green tea effects on cognition, mood and human brain function: a systematic review. Phytomedicine. 2017;34:26–37. https://doi.org/10.1016/j.phymed.2017.07.008.

Article  CAS  PubMed  Google Scholar 

Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Navarro V et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020:7:386–402. https://doi.org/10.1016/j.toxrep.2020.02.008.

Acosta L, Byham-Gray L, Kurzer M, Samavat H. Hepatotoxicity with high-dose green tea extract: Effect of Catechol-O-Methyltransferase and Uridine 5’-Diphospho-glucuronosyltransferase 1A4 genotypes. J Diet Suppl. 2023;20(6):850–69. https://doi.org/10.1080/19390211.2022.2128501.

留言 (0)

沒有登入
gif